Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

Arrythmia Clinical Trial

Official title:

Patient Directed Strategies for Cardiac Arrhythmia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05032495
• Other study ID #: 3174
• Status: Completed
• Start date: May 1, 2022
• Est. completion date: August 31, 2023

Study information

• Verified date: April 2024
• Source: Ottawa Heart Institute Research Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.

Description:

There will be four study groups:

1. Heart patients who experienced a cardiac arrhythmia while in hospital,

2. Heart patients who did not experience a cardiac arrhythmia while in hospital,

3. Heart patients with an upcoming procedure that have not had a cardiac arrhythmia,

4. Members of the general public.

There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: August 31, 2023
• Est. primary completion date: August 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion criteria:

• Upcoming or previous cardiac procedure.

Exclusion Criteria:

• Inability to complete an electronic survey or participate in a small group meeting.

Related Conditions & MeSH terms

• Arrhythmias, Cardiac
• Arrythmia

Intervention

Other:
• Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
• Focus group
To answer any questions and discuss topics covered in the standard presentation.

Locations

Country	Name	City	State
Canada	University of Ottawa Heart Insitute	Ottawa	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Ottawa Heart Institute Research Corporation

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey	accept a biological therapy	2 years